THE PREVALENCE OF ATRIAL FIBRILLATION CAUSES; A CROSS-SECTIONAL SURVEY AT A LARGE TEACHING HOSPITAL

U MAJEED; R AHMAD; M AQEEL; S KHAN; S KANWAL; MA BASHIR

doi:10.54112/bcsrj.v2024i1.905

Authors

U MAJEED Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
R AHMAD Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
M AQEEL Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
S KHAN Department of Anatomy, Al Nafees Medical College and Hospital Islamabad. Pakistan
S KANWAL Department of Physiology, Al Nafees Medical College and Hospital Islamabad, Pakistan
MA BASHIR Department of Physiology, Al Nafees Medical College and Hospital Islamabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.905

Keywords:

Atrial Fibrillation, Coronary Artery Disease, Diabetes Mellitus, Hypertension, Obesity, Presyncope, Valvular Disease

Abstract

The most frequent cause of atrial fibrillation is abnormalities or damage to the heart’s anatomy. Previous observations suggest that the prevalence of atrial fibrillation may be understated in high-income countries compared to low- and middle-income nations. Conversely, other findings indicate that the prevalence of atrial fibrillation in developed countries may be overstated compared to third-world countries. Objective: To determine the frequency of causes of atrial fibrillation in a tertiary care hospital and to evaluate the prevalence of atrial fibrillation etiology in this setting. Methods: This cross-sectional survey, conducted with a rigorous methodology, was carried out in the Department of Cardiology at Gulab Devi Hospital, Lahore, Pakistan, over six months, from December 18, 2018, to June 18, 2019. After receiving clearance from the hospital ethics committee, 250 patients diagnosed with atrial fibrillation and meeting the inclusion criteria were enrolled in the study. Written consent was obtained from all participants, and their demographics were recorded. Patients underwent ECG, ECHO, and other clinical assessment tests to evaluate the various causes of atrial fibrillation. Detailed histories of potential etiological factors were recorded using a structured proforma. Data were analyzed using appropriate statistical methods. Results: The mean age of the patients was 35.03 ± 12.29 years. Among the studied causes of atrial fibrillation, the prevalence of coronary kidney disease, diabetes mellitus, and hypertension were notably high, at 66%, 52.4%, and 41.4%, respectively. Other significant causes included coronary artery disease (12.4%), presyncope (13.2%), obesity (18%), and valvular disease (21.6%). Conclusion: The findings of this study revealed that the most prevalent causes of atrial fibrillation among the study population were coronary kidney disease, diabetes mellitus, and hypertension. Other significant etiological factors included coronary artery disease, presyncope, obesity, and valvular disease. These results highlight the need for targeted management strategies for atrial fibrillation in tertiary care settings.

Downloads

Download data is not yet available.

References

Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nature Reviews Cardiology. 2014;11(11):639-54.

Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. European Heart Journal. 2013;34(35):2746-51.

Gaztañaga L, Marchlinski FE, Betensky BP. Mechanisms of cardiac arrhythmias. Revista Española de Cardiología (English Edition). 2012;65(2):174-85.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87-108.

Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. Journal of the American College of Cardiology. 2014;64(7):660-8.

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213.

Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. Jama. 1994;271(11):840-4.

Movahed M-R, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. International journal of cardiology. 2005;105(3):315-8.

Chen M, Feng X, Sun J, Wang Q, Zhang P, Wang J, et al. Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways. IJC Heart & Vasculature. 2015;7:69-75.

Lau Y, Yiu K, Siu C, Tse H. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications. Journal of human hypertension. 2012;26(10):563-9.

Le Heuzey J-Y, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, et al. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. The American journal of cardiology. 2010;105(5):687-93.

Shah V, Desai T, Agrawal A. The association between chronic obstructive pulmonary disease (COPD) and atrial fibrillation: A review. Chron Obstruct Pulmon Dis. 2016;1(2).

Spirito P. Atrial fibrillation in hypertrophic cardiomyopathy: new light on an old problem. Am Heart Assoc; 2017. p. 2437-9.

Ducas R, Ariyarajah V. Atrial fibrillation in patients with ischemic and non-ischemic left ventricular dysfunction. Journal of atrial fibrillation. 2013;5(5).

Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, et al. Risk of new-onset atrial fibrillation about body mass index. Archives of internal medicine. 2006;166(21):2322-8.

Kivimäki M, Nyberg ST, Batty GD, Kawachi I, Jokela M, Alfredsson L, et al. Long working hours as a risk factor for atrial fibrillation: a multi-cohort study. European heart journal. 2017;38(34):2621-8.

Eggimann L, Blum S, Aeschbacher S, Reusser A, Ammann P, Erne P, et al. Risk factors for heart failure hospitalizations among patients with atrial fibrillation. PloS one. 2018;13(2):e0191736.

Mrozowska E, Krzemińska-Pakuła M, Rogowski W, Musiał W, Zasłonka J. Atrial fibrillation in mitral valve disease--risk factors. Polskie Archiwum Medycyny Wewnetrznej. 1999;101(1):45-53.

Stortecky S, Buellesfeld L, Wenaweser P, Heg D, Pilgrim T, Khattab AA, et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circulation: Cardiovascular Interventions. 2013;6(1):77-84.

Members WG, Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-e181.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. 2014;64(21):e1-e76.

Yang Y, Zhang Z, Ng CY, Li G, Liu T. Meta-analysis of CHADS2 score in predicting atrial fibrillation. The American journal of cardiology. 2015;116(4):554-62.

Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease–double trouble. Advances in medical sciences. 2018;63(1):30-5.